Tecan Group Valuation
Is TECN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TECN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TECN (CHF302.2) is trading below our estimate of fair value (CHF416.09)
Significantly Below Fair Value: TECN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TECN?
Other financial metrics that can be useful for relative valuation.
| What is TECN's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CHF 3.87b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.6x |
| Enterprise Value/EBITDA | 21.2x |
| PEG Ratio | 3.1x |
Price to Earnings Ratio vs Peers
How does TECN's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 52.9x | ||
SFZN Siegfried Holding | 35.9x | 14.7% | CHF 4.0b |
BANB Bachem Holding | 55.5x | 16.2% | CHF 6.2b |
SKAN SKAN Group | 68x | 19.4% | CHF 1.8b |
LONN Lonza Group | 52.2x | 20.6% | CHF 34.1b |
TECN Tecan Group | 29.3x | 9.5% | CHF 3.9b |
Price-To-Earnings vs Peers: TECN is good value based on its Price-To-Earnings Ratio (29.3x) compared to the peer average (52.9x).
Price to Earnings Ratio vs Industry
How does TECN's PE Ratio compare vs other companies in the European Life Sciences Industry?
Price-To-Earnings vs Industry: TECN is good value based on its Price-To-Earnings Ratio (29.3x) compared to the European Life Sciences industry average (36.6x).
Price to Earnings Ratio vs Fair Ratio
What is TECN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 29.3x |
| Fair PE Ratio | 21.1x |
Price-To-Earnings vs Fair Ratio: TECN is expensive based on its Price-To-Earnings Ratio (29.3x) compared to the estimated Fair Price-To-Earnings Ratio (21.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 302.20 | CHF 396.57 +31.2% | 5.8% | CHF 418.00 | CHF 347.00 | n/a | 7 |
| Jun ’25 | CHF 319.40 | CHF 397.71 +24.5% | 6.0% | CHF 420.00 | CHF 347.00 | n/a | 7 |
| May ’25 | CHF 327.00 | CHF 395.57 +21.0% | 7.2% | CHF 420.00 | CHF 332.00 | n/a | 7 |
| Apr ’25 | CHF 373.80 | CHF 397.14 +6.2% | 7.1% | CHF 420.00 | CHF 332.00 | n/a | 7 |
| Mar ’25 | CHF 350.00 | CHF 390.86 +11.7% | 10.5% | CHF 450.00 | CHF 311.00 | n/a | 7 |
| Feb ’25 | CHF 330.80 | CHF 392.29 +18.6% | 10.6% | CHF 450.00 | CHF 311.00 | n/a | 7 |
| Jan ’25 | CHF 343.40 | CHF 412.50 +20.1% | 14.8% | CHF 480.00 | CHF 300.00 | n/a | 6 |
| Dec ’24 | CHF 311.00 | CHF 435.00 +39.9% | 8.7% | CHF 480.00 | CHF 372.00 | n/a | 5 |
| Nov ’24 | CHF 265.80 | CHF 447.40 +68.3% | 4.9% | CHF 480.00 | CHF 417.00 | n/a | 5 |
| Oct ’24 | CHF 309.20 | CHF 447.83 +44.8% | 4.4% | CHF 480.00 | CHF 417.00 | n/a | 6 |
| Sep ’24 | CHF 352.80 | CHF 448.86 +27.2% | 4.1% | CHF 480.00 | CHF 417.00 | n/a | 7 |
| Aug ’24 | CHF 346.40 | CHF 466.86 +34.8% | 2.8% | CHF 485.00 | CHF 450.00 | n/a | 7 |
| Jul ’24 | CHF 343.20 | CHF 463.83 +35.1% | 2.6% | CHF 480.00 | CHF 450.00 | CHF 302.20 | 6 |
| Jun ’24 | CHF 350.20 | CHF 464.83 +32.7% | 2.4% | CHF 480.00 | CHF 450.00 | CHF 319.40 | 6 |
| May ’24 | CHF 387.80 | CHF 461.80 +19.1% | 2.2% | CHF 480.00 | CHF 450.00 | CHF 327.00 | 5 |
| Apr ’24 | CHF 399.20 | CHF 460.33 +15.3% | 4.3% | CHF 485.00 | CHF 425.00 | CHF 373.80 | 6 |
| Mar ’24 | CHF 378.20 | CHF 459.00 +21.4% | 5.0% | CHF 483.00 | CHF 425.00 | CHF 350.00 | 5 |
| Feb ’24 | CHF 382.60 | CHF 470.00 +22.8% | 4.2% | CHF 493.00 | CHF 440.00 | CHF 330.80 | 4 |
| Jan ’24 | CHF 412.40 | CHF 470.00 +14.0% | 4.2% | CHF 493.00 | CHF 440.00 | CHF 343.40 | 4 |
| Dec ’23 | CHF 399.60 | CHF 467.50 +17.0% | 3.6% | CHF 483.00 | CHF 440.00 | CHF 311.00 | 4 |
| Nov ’23 | CHF 356.60 | CHF 467.50 +31.1% | 3.6% | CHF 483.00 | CHF 440.00 | CHF 265.80 | 4 |
| Oct ’23 | CHF 343.00 | CHF 467.50 +36.3% | 3.6% | CHF 483.00 | CHF 440.00 | CHF 309.20 | 4 |
| Sep ’23 | CHF 345.20 | CHF 467.50 +35.4% | 3.6% | CHF 483.00 | CHF 440.00 | CHF 352.80 | 4 |
| Aug ’23 | CHF 336.40 | CHF 494.33 +46.9% | 6.1% | CHF 536.00 | CHF 467.00 | CHF 346.40 | 3 |
| Jul ’23 | CHF 285.80 | CHF 494.33 +73.0% | 6.1% | CHF 536.00 | CHF 467.00 | CHF 343.20 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.